This is an old revision of the document!

News and highlights

Immune Disease and the Microbiome: Healthcare in response to New Knowledge presented by Professor Trevor Marshall to the Predictive, Preventive and Personalized Medicine conference: Moscow, Russia. September 2016

Publications and presentations

Microbe-Microbe and Host-Microbe Interactions drive inflammatory processes - 2017 paper in Discovery medicine
Electrosmog and immune disease - paper in Immunologic research on modern sources of immune suppression
Immunostimulation in the era of the metagenome - collaborative paper in Cellular & molecular immunology

Complete list

About Marshall Protocol Recovery

Due to differences in molecular structure, each ARBA drug which is an angiotensin receptor blocker. One of the ARBs is olmesartan (Benicar). Not all ARBs activate the Vitamin D Receptor. is shown to have significantly different properties when interacting with the nuclear receptorsIntracellular receptor proteins that bind to hydrophobic signal molecules (such as steroid and thyroid hormones) or intracellular metabolites and are thus activated to bind to specific DNA sequences which affect transcription. in the immune cells. For example: where Telmisartan would quickly and completely suppress immune function, frequent dosing of OlmesartanMedication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. Also known by the trade name Benicar. over a prolonged period allows recovery of immune function via activation of the vitamin D receptor.
Data collected since 2004 supports the hypothesis that with the addition of diligent avoidance of every form of immune suppression overall health can be maintained and the body restored to natural homeostasis.

About Autoimmunity Research Foundation

Autoimmunity Research Foundation is a California-based non-profit organization formed to conduct scientific research into the cause and cure of autoimmune and non-autoimmune diseases, and to instruct the public on subjects related to disease, useful to individuals and beneficial to the community.

About the MPKB Project

The MPKB currently contains about 400 pages and draws from the best possible evidence to support its mission. As of May 2011, about 85% of those articles are complete with the remainder awaiting completion or revision.

sidebar.1522711956.txt.gz · Last modified: 04.02.2018 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.